Business
InMed Receives over $1,350,000 From Warrant Exercise
InMed Receives over $1,350,000 From Warrant Exercise Canada NewsWire VANCOUVER, ...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Receives over $1,350,000 From Warrant Exercise\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Feb. 27, 2017\n\n\n\nCSE: INOTCQB: IMLFF\n\n\n\nVANCOUVER, Feb. 27, 2017 /CNW/ - InMed Pharmaceuticals, Inc. (\"InMed\") (CSE: IN; OTCQB: IMLFF), reported today that prior to their expiry on Friday, February 24, 2017 a total of 10,672,750 common share purchase warrants have been exercised at a price of $0.13 per common share. Proceeds from the exercise of these warrants totalled $1,387,458 and 10,672,750 common shares were issued from InMed's Treasury.  \n\n\n \n \n\n \n\"We are grateful for this expression of confidence by our warrant holders. This infusion of capital further strengthens our balance sheet as we continue the execution of our business plan and corporate objectives for 2017\" said Chris Bogart, SVP of Investor Relations.\n\nNo commissions or placement fees have been paid related to the funds received from this warrant exercise. Proceeds raised are for general corporate purposes. \n\nAbout InMed \n\nInMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's proprietary in silico drug/disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company. For more information, visit www.inmedpharma.com\n\nForward Looking Statements\n\nThis news release contains \"forward-looking information\" and \"forward-looking statements\" (collectively, \"forward-looking information\") within the meaning of applicable securities laws.  Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.  Forward-looking information in this news release includes statemen...